Mehreen Zaka

Mehreen Zaka

Auto-generated profile, based on publicly available information

Mehreen Zaka

Northeastern University, Department of Pharmaceutical Sciences, Boston, Massachusetts 02115, U.S.A

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JXJie Xu
Jie Xu
ASAna Santa-Cruz
Ana Santa-Cruz
ACAishwarya Chandrashekar
Aishwarya Chandrashekar
TKTakeharu Kawano
Takeharu Kawano
RKR. Charles Kissell
R. Charles Kissell
LPLeigh Daniel Plant
Leigh Daniel Plant
TMEM16A channels conduct Ca 2+ -activated Cl − currents that underlie essential physiological processes including epithelial secretion, smooth muscle contraction, and sensory transduction. Channel activation requires both intracellular Ca 2+ and the signaling phospholipid phosphatidylinositol 4,5-bisphosphate (PIP 2 ), yet the molecular basis of this dual regulation has remained unclear. Using gating molecular-dynamics simulations and structure-guided electrophysiology, we show that PIP 2 and Ca 2+ cooperatively gate TMEM16A through an allosterically coupled electrostatic network centered on the α4 helix. Specific PIP 2 headgroup phosphate interactions are essential for coupling Ca 2+ binding to channel opening, while the PIP 2 acyl chains engage hydrophobic surfaces of the helix to stabilize the open conformation. Disrupting either component of this lipid–protein interface reduces apparent PIP 2 affinity and impairs activation, whereas long-chain PIP 2 fully restores wild-type activity. These interactions act in concert with Ca 2+ -dependent structural rearrangements that widen the conduction pathway and enable Cl − permeation. Our findings establish that both the headgroup phosphates and acyl chains of PIP 2 play indispensable and complementary roles in TMEM16A gating. This mechanism defines a cooperative lipid–ion activation process that provides a general framework for understanding phosphoinositide regulation of ion channels and offers opportunities for structure-based design of TMEM16A modulators.

11 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MGManos Gkikas
Manos Gkikas
EDEvangelos Dadiotis
Evangelos Dadiotis
MZMehreen Zaka
Mehreen Zaka
Nihal AlyNihal Aly
Nihal Aly
KCKim Chan
Kim Chan
Diomedes Elias LogothetisDiomedes Elias Logothetis
Diomedes Elias Logothetis
Ion channels are pore-forming transmembrane proteins that allow ions to move down an electrochemical gradient and across the channel pore and regulate many cell functions. Among them, are the G-protein–gated inwardly-rectifying K+ channels 1 (GIRK1) that are ubiquitously expressed with major functions in the brain and heart. Interestingly, significantly higher GIRK1 expression has been found in estrogen receptor positive (ER+) breast cancer patients compared to patients with HER2+ tumors or normal patients, and that was statistically correlated with shorter survival times and metastatic potential. Herein, we report the preparation of ∼4 nm GAT1508 -coated poly(ethylene glycol) gold nanoparticle (PEGylated AuNP) biomarker for ER+ breast cancer cell screening through an optical microscope. A urea-based small molecule, GAT1508, with an N-methylpyrazole benzyl group on one side and a bromo-thiophene tail on the other side, has been shown to predominantly bind GIRK1 subunits and specifically activate GIRK1/2 channels. Two derivatives of GAT1508were synthesized and characterized: an ethylamine derivative (GAT1508-EA) with a chain extension from the benzyl ring, and a propylamine derivative (GAT1508-PA) with a chain extension from the pyrazole ring. Electrophysiology (TEVC and whole-cell patch-clump) experiments as well as fluorescence studies (Thallium assay) showed that only GAT1508-PA inhibited GIRK1/2-mediated K+ currents in transfected HEK293 GIRK1 cells. Docking studies showed strong binding for the propylamine GAT1508 derivative, both in the amine form (GAT1508-PA) as well as in the amide form (GAT1508-PA-EG2; coupled with PEG as in the AuNPs). GAT1508 -PEG-AuNPs ( GAT1508 -NPs) were synthesized subsequently with ∼65 wt% metal loading. UV-Vis studies revealed the presence of the conjugated ligand at 260 nm. Flow cytometry studies showed binding of Alexa 594-labeled GAT1508 -NPs in ER+ MCF-7 breast cancer cells with a strong interaction, while incubation of fixed MCF-7 cells with a GAT1508 -NP solution led to optical detection of ER+ breast cancer cells, without the need of fluorescent dyes and additional amplification steps. Detection was not feasible in MDA-MB-231 cells, a triple (-) breast cell line that does not express GIRK1. This is the first study, to our knowledge, that couples nanotechnology with small molecule drug design and electrophysiology to develop ion channel-tracing molecular probes for the detection/screening of ER+ breast cancer.